European Respiratory Society International Congress 2017: highlights from the Clinical Assembly (original) (raw)
Related papers
European Respiratory Society International Congress 2015
The Lancet Respiratory Medicine, 2015
This article contains highlights and a selection of the scientific advances from the European Respiratory Society's Clinical Assembly (Assembly 1 and its six respective groups) that were presented at the 2017 European Respiratory Society International Congress in Milan, Italy. The most relevant topics from each of the groups will be discussed, covering a wide range of areas including clinical problems, rehabilitation and chronic care, thoracic imaging, interventional pulmonology, diffuse and parenchymal lung diseases, and general practice and primary care. In this comprehensive review, the newest research and actual data as well as award-winning abstracts and highlight sessions will be discussed.
ERS International Congress 2021: highlights from the Allied Respiratory Professionals assembly
ERJ Open Research, 2022
This paper provides an overview of some of the most memorable sessions that were (co)organised by the Allied Respiratory Professionals Assembly during the 2021 European Respiratory Society International Congress, which was held online for the second consecutive year due to the COVID-19 pandemic. Early Career Members from Assembly 9 summarised the content of the sessions (three oral communication sessions, two symposia and one Expert View) with the support of the chairs from the four Assembly groups: Respiratory Function Technologists and Scientists (Group 9.01); Physiotherapists (Group 9.02); Nurses (Group 9.03); and Psychologists and Behavioural Scientists (Group 9.04). The sessions covered the following topics: impact of COVID-19 on lung function and healthcare services, and the importance of quality assurance and technology in lung function assessment; diagnosis and management of sarcopenia in patients with chronic respiratory disease; maintenance of the effects of pulmonary reha...
Respirology (Carlton, Vic.), 2017
Respirology has made important contributions related to respiratory infections over the past year. In this review, we focus on bronchiectasis, pneumonia, tuberculosis and non-tuberculous mycobacteria infections as the most relevant topics in the area of respiratory diseases. 1.1. Bronchiectasis Park et al. reported a study of 155 patients with bronchiectasis to identify the predictors of radiological progression of the disease. 1 Treatment in bronchiectasis aims to reduce inflammation and airway infection to prevent further lung damage. 2 Therefore identifying the drivers of poor outcome is important. In this analysis, older patients, those with lower body mass index (BMI) and patients infected with Pseudomonas aeruginosa or non-tuberculous mycobacteria (NTM) were more likely to show radiological progression, measured using the Bhalla score. 1 In multivariable analysis, only P. aeruginosa and BMI were statistically significant. The results are supported by existing literature. P. aeruginosa colonisation and BMI are both incorporated into the bronchiectasis severity index, a validated prediction tool, and P. aeruginosa in particular is strongly associated with other indicators of progression such as quality of life, forced expiratory volume in one second (FEV1), exacerbation frequency and mortality. 3,4 However, the most important step in the treatment of bronchiectasis is identifying the underlying cause, since many causes such as NTM infection, rheumatoid arthritis, primary ciliary dyskinesia, immunodeficiency or allergic bronchopulmonary aspergillosis require specific treatments. 5,6 Gao et al. 7 conducted a systematic review into the underlying causes of bronchiectasis identified in 56 studies (N=8608). 7 The study was limited by the high variability in testing across different studies, and the variable definitions used, but was able to suggest that 18.3% of bronchiectasis patients have an aetiology with a specific treatment. 7
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly
ERJ Open Research, 2020
This article discusses a selection of the scientific presentations in the field of interstitial lung diseases (ILDs) that took place at the 2019 European Respiratory Society International Congress in Madrid, Spain. There were sessions from all four groups within Assembly 12: group 12.01 “Idiopathic interstitial pneumonias”, group 12.02 “ILDs/diffuse parenchymal lung diseases (DPLDs) of known origin”, group 12.03 “Sarcoidosis and other granulomatous ILDs/DPLDs” and group 12.04 “Rare ILDs/DPLDs”. The presented studies brought cutting-edge developments on several aspects of these conditions, including pathogenesis, diagnosis and treatment. As many of the ILDs are individually rare, the sharing of experiences and new data that occur during the Congress are very important for physicians interested in ILDs and ILD patients alike.
Review of the British Thoracic Society Winter Meeting 2013, 4-6 December, London, UK
Thorax, 2014
This article reviews the British Thoracic Society Winter Meeting 2013, the annual scientific meeting attended by over 2000 delegates and representing the depth and breadth of UK respiratory medicine. This year's meeting from 4 to 6 December in London featured cutting-edge research alongside keynote symposia from international experts in respiratory science, epidemiology and clinical trials. This article reviews the key symposia and selected abstract sessions from the 2013 meeting.
Breathe, 2021
The Lung Science Conference (LSC) and the Sleep and Breathing Conference (SBC) are two conferences organised by the European Respiratory Society (ERS), the latter held in association with the European Sleep Research Society. This year, the LSC and SBC were both held in a virtual format with the participation of researchers and clinicians from around the world. The participation of Early Career Members (ECMs) was notable in both events: 216 of 363 (60%) delegates attending the LSC were under 40 years old, and 315 of 920 (34%) delegates were ≤40 years of age at the SBC. Both conferences included outstanding talks on the most recent advances in respiratory medicine and science, oral/poster communication sessions on novel research, exciting opportunities to network with peers, and much more! This article provides a brief description of some of the most remarkable sessions of the @EuroRespSoc Lung Science Conference and the Sleep and Breathing Conference 2021 and presents the new incomin...